Regulation of RMs in the global -- Health technology assessment of RMs -- Challenges for market access of RMs -- Impact of COVID-19 on the RMs industry -- Partnerships to expediate successful market access of RMs -- Business models and commercial considerations for gene and cell therapies -- Summary of recommendation and perspective for future research.